Market Closed -
Nasdaq Copenhagen
10:59:41 2024-05-07 am EDT
|
5-day change
|
1st Jan Change
|
34.2
DKK
|
+1.97%
|
|
+0.47%
|
+4.40%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
25,433
|
31,719
|
32,973
|
-
|
-
|
Enterprise Value (EV)
1 |
27,464
|
31,008
|
28,520
|
24,865
|
20,959
|
P/E ratio
|
13.5
x
|
14.2
x
|
11.3
x
|
9.88
x
|
8.86
x
|
Yield
|
2.23%
|
2.14%
|
2.6%
|
2.98%
|
3.48%
|
Capitalization / Revenue
|
1.39
x
|
1.59
x
|
1.57
x
|
1.51
x
|
1.46
x
|
EV / Revenue
|
1.51
x
|
1.56
x
|
1.36
x
|
1.14
x
|
0.93
x
|
EV / EBITDA
|
5.89
x
|
5.49
x
|
4.76
x
|
3.86
x
|
3.02
x
|
EV / FCF
|
10.2
x
|
8.66
x
|
6.39
x
|
5.47
x
|
4.23
x
|
FCF Yield
|
9.83%
|
11.5%
|
15.6%
|
18.3%
|
23.7%
|
Price to Book
|
1.24
x
|
1.47
x
|
1.38
x
|
1.24
x
|
1.11
x
|
Nbr of stocks (in thousands)
|
992,840
|
992,840
|
992,011
|
-
|
-
|
Reference price
2 |
26.05
|
32.76
|
34.20
|
34.20
|
34.20
|
Announcement Date
|
2/7/23
|
2/7/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
17,036
|
17,672
|
16,299
|
18,246
|
19,912
|
21,020
|
21,870
|
22,643
|
EBITDA
1 |
4,823
|
4,783
|
3,720
|
4,663
|
5,652
|
5,996
|
6,450
|
6,946
|
EBIT
1 |
3,608
|
1,990
|
2,010
|
2,852
|
3,195
|
4,290
|
4,891
|
5,399
|
Operating Margin
|
21.18%
|
11.26%
|
12.33%
|
15.63%
|
16.05%
|
20.41%
|
22.36%
|
23.84%
|
Earnings before Tax (EBT)
1 |
3,481
|
1,906
|
1,581
|
2,474
|
2,993
|
3,970
|
4,544
|
5,018
|
Net income
1 |
2,667
|
1,581
|
1,318
|
1,916
|
2,290
|
3,001
|
3,426
|
3,845
|
Net margin
|
15.66%
|
8.95%
|
8.09%
|
10.5%
|
11.5%
|
14.28%
|
15.66%
|
16.98%
|
EPS
2 |
-
|
-
|
-
|
1.930
|
2.310
|
3.035
|
3.463
|
3.861
|
Free Cash Flow
1 |
2,169
|
3,360
|
1,662
|
2,699
|
3,579
|
4,461
|
4,550
|
4,957
|
FCF margin
|
12.73%
|
19.01%
|
10.2%
|
14.79%
|
17.97%
|
21.22%
|
20.8%
|
21.89%
|
FCF Conversion (EBITDA)
|
44.97%
|
70.25%
|
44.68%
|
57.88%
|
63.32%
|
74.4%
|
70.54%
|
71.36%
|
FCF Conversion (Net income)
|
81.33%
|
212.52%
|
126.1%
|
140.87%
|
156.29%
|
148.65%
|
132.81%
|
128.94%
|
Dividend per Share
2 |
-
|
-
|
-
|
0.5800
|
0.7000
|
0.8897
|
1.018
|
1.191
|
Announcement Date
|
2/6/20
|
2/4/21
|
2/9/22
|
2/7/23
|
2/7/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
4,013
|
4,053
|
4,372
|
4,475
|
4,719
|
4,680
|
5,044
|
4,938
|
4,952
|
4,978
|
5,194
|
5,232
|
5,301
|
5,289
|
5,534
|
EBITDA
1 |
933
|
440
|
1,290
|
1,049
|
1,414
|
910
|
1,845
|
1,493
|
1,521
|
793
|
1,550
|
1,574
|
1,551
|
1,489
|
1,674
|
EBIT
1 |
526
|
6
|
875
|
622
|
952
|
403
|
1,233
|
840
|
891
|
231
|
1,060
|
1,010
|
1,020
|
952
|
1,180
|
Operating Margin
|
13.11%
|
0.15%
|
20.01%
|
13.9%
|
20.17%
|
8.61%
|
24.44%
|
17.01%
|
17.99%
|
4.64%
|
20.42%
|
19.31%
|
19.25%
|
18%
|
21.32%
|
Earnings before Tax (EBT)
1 |
412
|
-112
|
528
|
647
|
882
|
417
|
1,150
|
785
|
883
|
175
|
1,057
|
975
|
951.5
|
935.5
|
1,184
|
Net income
1 |
321
|
-2
|
412
|
505
|
688
|
311
|
880
|
600
|
676
|
134
|
875.4
|
819.2
|
826.6
|
678.2
|
911
|
Net margin
|
8%
|
-0.05%
|
9.42%
|
11.28%
|
14.58%
|
6.65%
|
17.45%
|
12.15%
|
13.65%
|
2.69%
|
16.86%
|
15.66%
|
15.59%
|
12.82%
|
16.46%
|
EPS
2 |
-
|
-
|
-
|
0.5100
|
0.6900
|
0.3100
|
0.8900
|
0.6000
|
0.6800
|
0.1400
|
0.8132
|
0.7671
|
0.7756
|
0.6702
|
0.9200
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
0.5800
|
-
|
-
|
-
|
0.7000
|
-
|
-
|
-
|
0.4775
|
-
|
Announcement Date
|
11/10/21
|
2/9/22
|
5/11/22
|
8/17/22
|
11/9/22
|
2/7/23
|
5/10/23
|
8/16/23
|
11/8/23
|
2/7/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
6,625
|
3,966
|
3,043
|
2,031
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
711
|
4,454
|
8,108
|
12,014
|
Leverage (Debt/EBITDA)
|
1.374
x
|
0.8292
x
|
0.818
x
|
0.4356
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
2,169
|
3,360
|
1,662
|
2,699
|
3,579
|
4,461
|
4,550
|
4,957
|
ROE (net income / shareholders' equity)
|
26.8%
|
9.37%
|
14.2%
|
16.4%
|
10.7%
|
16.2%
|
15.4%
|
15.4%
|
ROA (Net income/ Total Assets)
|
13.2%
|
4.4%
|
7.07%
|
8.87%
|
6.12%
|
8.79%
|
9.08%
|
9.26%
|
Assets
1 |
20,266
|
35,893
|
18,647
|
21,606
|
37,429
|
34,150
|
37,731
|
41,533
|
Book Value Per Share
2 |
-
|
-
|
-
|
20.90
|
22.20
|
24.80
|
27.60
|
30.80
|
Cash Flow per Share
2 |
-
|
-
|
-
|
3.540
|
4.110
|
4.720
|
5.100
|
5.170
|
Capex
1 |
440
|
477
|
610
|
820
|
501
|
529
|
634
|
566
|
Capex / Sales
|
2.58%
|
2.7%
|
3.74%
|
4.49%
|
2.52%
|
2.52%
|
2.9%
|
2.5%
|
Announcement Date
|
2/6/20
|
2/4/21
|
2/9/22
|
2/7/23
|
2/7/24
|
-
|
-
|
-
|
Last Close Price
34.2
DKK Average target price
38.71
DKK Spread / Average Target +13.18% Consensus |
1st Jan change
|
Capi.
|
---|
| +4.40% | 4.76B | | +17.88% | 71.72B | | -1.07% | 24.29B | | +8.01% | 8.31B | | -18.28% | 8.22B | | +2.69% | 8.16B | | +16.55% | 4.31B | | -0.70% | 4.1B | | -2.20% | 3.91B | | +26.24% | 3.78B |
Pharmaceuticals Wholesale
|